临床消化病杂志
臨床消化病雜誌
림상소화병잡지
Chinese Journal of Clinical Gastroenterology
2015年
4期
228-229,230
,共3页
反流性食管炎%胃食管反流病%赛胃安胶囊
反流性食管炎%胃食管反流病%賽胃安膠囊
반류성식관염%위식관반류병%새위안효낭
saiweian capsule%gastroesophageal reflux disease%reflux esophagitis
[目的]观察赛胃安胶囊对反流性食管炎的疗效。[方法]80例反流性食管炎患者按入组先后分为治疗组、对照组,每组40例。对照组予以耐信+莫沙必利治疗,治疗组在对照组治疗的基础上加服赛胃安胶囊。比较2组患者治疗1周、8周后临床症状变化,同时比较治疗8周后内镜下食管炎改善情况。[结果]治疗1周后,治疗组临床症状改善为显效31例、有效8例、无效1例,总有效率为97.5%;对照组显效23例、有效12例、无效5例,总有效率87.5%;治疗组疗效优于对照组,差异有统计学意义( P<0.05)。治疗8周后,治疗组显效37例、有效3例、无效0例,总有效率100%;对照组显效34例、有效4例、无效2例,总有效率95.0%;治疗组疗效优于对照组,但差异无统计学意义( P>0.05)。治疗8周后反流性食管炎恢复情况,治疗组显效33例、有效5例、无效2例,总有效率95.0%;对照组显效24例、有效12例、无效4例,总有效率90.0%;治疗组明显优于对照组( P<0.05)。[结论]赛胃安胶囊能促进反流性食管炎的愈合,并有助于改善反流性食管炎的临床症状。
[目的]觀察賽胃安膠囊對反流性食管炎的療效。[方法]80例反流性食管炎患者按入組先後分為治療組、對照組,每組40例。對照組予以耐信+莫沙必利治療,治療組在對照組治療的基礎上加服賽胃安膠囊。比較2組患者治療1週、8週後臨床癥狀變化,同時比較治療8週後內鏡下食管炎改善情況。[結果]治療1週後,治療組臨床癥狀改善為顯效31例、有效8例、無效1例,總有效率為97.5%;對照組顯效23例、有效12例、無效5例,總有效率87.5%;治療組療效優于對照組,差異有統計學意義( P<0.05)。治療8週後,治療組顯效37例、有效3例、無效0例,總有效率100%;對照組顯效34例、有效4例、無效2例,總有效率95.0%;治療組療效優于對照組,但差異無統計學意義( P>0.05)。治療8週後反流性食管炎恢複情況,治療組顯效33例、有效5例、無效2例,總有效率95.0%;對照組顯效24例、有效12例、無效4例,總有效率90.0%;治療組明顯優于對照組( P<0.05)。[結論]賽胃安膠囊能促進反流性食管炎的愈閤,併有助于改善反流性食管炎的臨床癥狀。
[목적]관찰새위안효낭대반류성식관염적료효。[방법]80례반류성식관염환자안입조선후분위치료조、대조조,매조40례。대조조여이내신+막사필리치료,치료조재대조조치료적기출상가복새위안효낭。비교2조환자치료1주、8주후림상증상변화,동시비교치료8주후내경하식관염개선정황。[결과]치료1주후,치료조림상증상개선위현효31례、유효8례、무효1례,총유효솔위97.5%;대조조현효23례、유효12례、무효5례,총유효솔87.5%;치료조료효우우대조조,차이유통계학의의( P<0.05)。치료8주후,치료조현효37례、유효3례、무효0례,총유효솔100%;대조조현효34례、유효4례、무효2례,총유효솔95.0%;치료조료효우우대조조,단차이무통계학의의( P>0.05)。치료8주후반류성식관염회복정황,치료조현효33례、유효5례、무효2례,총유효솔95.0%;대조조현효24례、유효12례、무효4례,총유효솔90.0%;치료조명현우우대조조( P<0.05)。[결론]새위안효낭능촉진반류성식관염적유합,병유조우개선반류성식관염적림상증상。
Objective]To evaluate the efficacy of Saiweian Capsule in treating reflux esophagitis. [Meth‐ods]Eighty patients were divided into two groups 40 cases treated with Nexium + mosapride + Saiweian Capsule(group A) ,40 cases treated with Nexium + mosapride(group B). The clinical symptoms between group A and group B after 1 week and after 8 weeks of treatment were compared. The change of endoscopic reflux esophagitis after 8 weeks of treatment was also compared. [Results]After 1 week treatment ,the change of clinical symptoms of group A was 31 cases apparent ,6 cases effective ,1 case invalid ,group B was 23 cases apparent ,12 cases effective ,5 cases invalid. The response of group A was more obvious than group B with statistical difference(P<0.05).After 8 weeks treatment the change of clinical symptoms of group A was 37 cases apparent ,3 cases effective ,0 cases invalid ,while the resulf of group B was 34 cases appar‐ent ,4 cases effective ,2 cases invalid .The result of group A was slightly better than group B with no statis‐tical difference(P>0.05). The change of endoscopic reflux esophagitis in group A was 33 cases apparent ,5 cases effective ,2 cases invalid ,group B was 24 cases apparent ,12 cases effective ,4 cases invalid ,the result of group A was much better than group B ,there was statistical difference(P<0.05). [Conclusion]Saiweian Capsule can promote the healing of reflux esophagitis ,and may contribute to the improvement of clinical symptoms of reflux esophagitis.